Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pacific Biosciences
(NQ:
PACB
)
1.560
+0.120 (+8.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pacific Biosciences
< Previous
1
2
3
4
5
6
7
Next >
Earnings Scheduled For August 3, 2021
August 03, 2021
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to...
Via
Benzinga
Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding
July 20, 2021
Pacific Biosciences of California Inc (NASDAQ: PACB) has agreed to acquire Omniome, a San Diego-based company developing a short-read sequencing platform. Under...
Via
Benzinga
This Biotech Just Made History. Will Its Stock Follow?
June 04, 2021
Twenty years after the human genome was sequenced, a new wave of discovery has begun.
Via
The Motley Fool
2 Winners for a Drug Development Future That Looks Nothing Like the Past
June 04, 2021
A new breed of disruptors is delivering breakthroughs in genomics.
Via
The Motley Fool
2 Top Biotech Picks to Buy and Hold for the Next 10 Years
May 29, 2021
Incredible scientific advances could reward investors -- if they have the patience.
Via
The Motley Fool
Cathie Wood's Ark Loads Up Further On Tesla And Cuts Apple Stake
May 19, 2021
Cathie Wood-led Ark Investment Management on Tuesday snapped up $27.2 million worth of shares in Tesla Inc (NASDAQ: TSLA) after a two-week gap during which shares of the...
Via
Benzinga
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
May 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
COVID-19
'SPACs Attack' Recap: Looking Back At 8 SPAC Deals Plus Latest SPAC Headlines And Earnings
May 16, 2021
Last week featured eight announced SPAC deals. The week also had earnings from several well-known former SPACs. Here is a look back at the week that was SPACs for deals and...
Via
Benzinga
Earnings Scheduled For April 29, 2021
April 29, 2021
Companies Reporting Before The Bell • OSI Systems (NASDAQ:OSIS) is estimated to report quarterly earnings at $1.33 per share on revenue of $290.51 million. •...
Via
Benzinga
Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase
May 18, 2021
Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ:
Via
Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
May 14, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know
May 16, 2021
Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and...
Via
Benzinga
3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming
May 13, 2021
Falling costs are ushering in a new era of screening for a dreaded disease.
Via
The Motley Fool
Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day
May 14, 2021
Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first...
Via
Benzinga
What Investors Should Know About Ginkgo Bioworks SPAC Deal: 'Cell Programming Has The Potential To Impact Every Physical Goods Industry'
May 11, 2021
A well seasoned SPAC management team announced a SPAC deal Tuesday to bring a cell programming company public. The SPAC Deal: Ginkgo Bioworks is going public in a SPAC deal with...
Via
Benzinga
Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat
May 12, 2021
Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics...
Via
Benzinga
32 Stocks Moving In Monday's Mid-Day Session
May 03, 2021
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares jumped 99.7% to $14.42 after jumping 38% on Friday. Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 30.5% to $64....
Via
Benzinga
52 Biggest Movers From Yesterday
May 04, 2021
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday. Image Sensing Systems, Inc. (NASDAQ: ISNS)...
Via
Benzinga
Why Pacific Biosciences of California Stock Is Down Today
April 30, 2021
The company released its first-quarter earnings report, but that doesn't tell the whole story.
Via
The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
April 30, 2021
Gainers Motus GI Hldgs (NASDAQ:MOTS) stock moved upwards by 30.17% to $1.42 during Friday's regular session. As of 12:31 EST, this security is trading at a volume of...
Via
Benzinga
55 Biggest Movers From Friday
May 03, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) jumped 45.5% to close at $49.80 on Friday after dropping around 22% on Thursday. Brooklyn ImmunoTherapeutics acquired...
Via
Benzinga
38 Stocks Moving In Friday's Mid-Day Session
April 30, 2021
Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 29.2% to $5.93 after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 30, 2021
Gainers Motus GI Hldgs (NASDAQ:MOTS) stock increased by 46.78% to $1.6 during Friday's pre-market session. The market value of their outstanding shares is at $74.7...
Via
Benzinga
Pacific Biosciences of California (PACB) Q1 2021 Earnings Call Transcript
April 30, 2021
PACB earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Pacific Biosciences: Q1 Earnings Insights
April 29, 2021
Shares of Pacific Biosciences (NASDAQ:PACB) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 4600.00% over the past...
Via
Benzinga
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
April 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...
Via
Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.